In TME, certain tumor ligands bind to inhibitory molecules on T cells, such as CTLA-4, PD-1, TIM-3, and LAG-3 and others, which in turn produce immune-suppressive mediators, leading to the failure of cancer elimination [18, 38]. Here, HAVCR2 is linked to neoplasm.